Tcelltech, a spin-out of the German Cancer Research Center (DKFZ), 
offers enabling technologies for the development of next generation cancer immunotherapies.  

We have developed two main technology platforms:

(I) Discovery: an AI bioinformatics platform to identify tumor reactive T cell receptors (selecTCR) 

(II) Delivery: a high performance gene expression DNA vector platform for cell and gene therapy (nanoSMAR)